2005

• 03/01/2005

  CoreValve receives German government's approval to initiate clinical trial using its revalving™ system to percutaneously replace diseased aortic heart valves

• 01/01/2005

  Best Wishes for 2005

• 05/01/2005

  Diatos acquires oncology product rights from Macromed

• 10/01/2005

  Biolipox successfully completes million financing round – Scandinavian Life Science Venture new investor

• 17/01/2005

  Addex Pharmaceuticals enters into Collaboration with Ortho-McNeil Pharmaceutical to Develop Novel Treatments for Anxiety, Depression, Schizophrenia and Alzheimer's disease

• 17/01/2005

  Addex Pharmaceuticals signe un accord de développement avec Ortho-McNeil Pharmaceutical pour de nouveaux traitements pour l’anxiété, la dépression, la schizophrénie et la maladie d’Alzheimer

• 19/01/2005

  U.S patent & trademark office issues patent no 6,830,584 to CoreValve for its 'device for replacing a cardiac valve by percutaneous route'

• 27/01/2005

  Diatos named by Tornado insider amoung europe's Top 100 private tech companies - Best Performing Companies of 2004 -

• 27/01/2005

  XYOTAXTM Pivotal Trial in Non-Small Cell Lung Cancer, STELLAR 3, Reaches Required Number of Events

• 28/01/2005

  Esmertec and MontaVista Software to deliver integrated Java-Linux solutions for mobile phones

• 28/01/2005

  Esmertec et MontaVista Software proposent des solutions Java-Linux intégrées pour terminaux Mobiles

• 02/02/2005

  Esmertec Acquires Mobile Division of CoreTek Systems, China

• 02/02/2005

  Esmertec acquiert la Division Mobile de CoreTek Systems, en Chine

• 07/02/2005

  Sofinnova Partners annonce la clôture de son 5ième fonds

• 07/02/2005

  Sofinnova Partners Closes Fifth Fund at €385 Million

• 08/02/2005

  XYOTAX Patent Allowance Provides Exclusivity in Europe Until 2017

• 08/02/2005

  WebSideStory Announces Agreement to Acquire Atomz and Launch of Active Marketing Suite

• 16/02/2005

  Important soutien financier en faveur des recherches sur le cancer de DIATOS N.V.

• 16/02/2005

  DIATOS N.V.’s oncology research boosted by significant funding

• 22/02/2005

  SpineVision® receives FDA clearance for PediGuard™,world’s first and only free-hand drilling instrument able to detect an inadvertent breach in the vertebral pedicle or vertebral body

• 22/02/2005

  SpineVision® receives FDA clearance for PediGuard™,world’s first and only free-hand drilling instrument able to detect an inadvertent breach in the vertebral pedicle or vertebral body

• 08/03/2005

  CoTherix Reports Positive Clinical Data From STEP Study

• 10/03/2005

  Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards

• 10/03/2005

  Sofinnova Parners voted European VC Firm of the year in Global Private Equity Awards

• 16/03/2005

  Cellzome Announces Drug Discovery Collaboration in Alzheimer's Disease with Ortho-McNeil Pharmaceutical

• 16/03/2005

  Varioptic to demonstrate the world's first liquid zoom lens for camera phones at Cebit

• 15/03/2005

  IDM et Epimmune projettent de fusionner leurs activités

• 17/03/2005

  Epimmune and IDM agree to combine businesse

• 22/03/2005

  CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension

• 22/03/2005

  CoTherix's Ventavis(R) Commercially Available for the Treatment of Pulmonary Arterial Hypertension

• 24/03/2005

  Jean Schmitt named managing Partner at Sofinnova Partners

• 24/03/2005

  Nomination de Jean Schmitt comme Partenaire-Associé chez Sofinnova Partners

• 24/03/2005

  Q&A Jean Schmitt 3GSM 2005

• 24/03/2005

  Q&A Jean Schmitt 3GSM 2005

• 06/04/2005

  Esmertec acquires majority stake in eValley, Japan

• 06/04/2005

  Esmertec prend le contrôle de eValley, Japon

• 08/04/2005

  CoTherix Enters Into Agreement with Quadrant for Development of Extended-Release Formulation of Ventavis

• 08/04/2005

  CoTherix Enters Into Agreement with Quadrant for Development of Extended-Release Formulation of Ventavis

• 04/04/2005

  Two-Month Follow-up of first South-American patient shows 58-year-old female is fully recovered and has resumed normal activity after non-surgical replacement of defective aortic heart valve using Corevalve's breakthrough ReValving™ procedure

• 12/04/2005

  Neuro3d Reports Positive Results from Phase II Trials of Ocaperidone in Schizophrenia

• 12/04/2005

  Diatos S.A. opens its US subsidiary in California - Diatos USA, Inc.

• 14/04/2005

  Diatos named among the 2005 red herring 100 Europe

• 26/04/2005

  GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry

• 26/04/2005

  GPC Biotech and Ingenium Receive € 2.2 Million Joint Drug Discovery Grant from German Ministry

• 12/05/2005

  6WIND conclut un accord de développement stratégique sur les TIC avec l'académie des sciences de Chine

• 12/05/2005

  6WIND announces R&D partnership with China academy of science

• 16/05/2005

  Corevalve reports it has certified its Irvine, Calif., clean room operations to be used in manufacturing company's Revalving™ system for percutaneous aortic valve replacement (PAVR)

• 16/05/2005

  Corevalve reports it has certified its Irvine, Calif., clean room operations to be used in manufacturing company's Revalving™ system for percutaneous aortic valve replacement (PAVR)

• 16/05/2005

  New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference

• 16/05/2005

  New Ventavis(R) Data to Be Presented at American Thoracic Society's International Conference

• 17/05/2005

  DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology

• 17/05/2005

  DIATOS and SERVIER announce oncology research collaboration using the VECTOCELL® technology

• 17/05/2005

  DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.

• 17/05/2005

  DIATOS S.A. opens its US subsidiary in California – DIATOS USA, INC.

• 19/05/2005

  ALTITUDE n°1 - A newsletter from Sofinnova Partners

• 23/05/2005

  Evaluer les investissements à leur "juste valeur"

• 19/05/2005

  ALTITUDE n°1 - A newsletter from Sofinnova Partners

• 23/05/2005

  Evaluating assets at their Fair Value

• 23/05/2005

  Cellzome announces exercise of option to Alzheimer’s disease compounds by Ortho-McNeil Pharmaceutical

• 23/05/2005

  Cellzome announces exercise of option to Alzheimer’s disease compounds by Ortho-McNeil Pharmaceutical

• 07/06/2005

  OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module

• 07/06/2005

  OXXIUS Shrinks DPSS Lasers and announces world’s smallest blue laser module

• 20/06/2005

  Sofinnova Partners invests €4 million in Endotis Pharma

• 20/06/2005

  Sofinnova Partners investit 4 millions d'euros dans Endotis Pharma

• 14/06/2005

  6WIND reinstates defense roots with strategy and software launch for net-centric warfare communications

• 14/06/2005

  6WIND poursuit son engagement stratégique pour répondre aux défis des systèmes de communications de la défense

• 27/06/2005

  Esmertec et LG Electronics présentent un mobile doté d’une JVM (Java Virtual Machine) multi-tâches

• 27/06/2005

  Esmertec and LG Electronics Demonstrate Multi-tasking Java Virtual Machine on a Mobile Handset

• 28/06/2005

  Revolt technology receives €7 million in first round of financing

• 05/07/2005

  Esmertec decides to postpone its IPO

• 08/07/2005

  Esmertec a officiellement ouvert son Centre de recherche et de développement et d’assistance à la clientèle à Chengdu, en Chine

• 06/07/2005

  Esmertec officially opened its R&D and Customer Support Center in Chengdu, China

• 28/07/2005

  WebSideStory Announces Record Second Quarter 2005 Results

• 22/08/2005

  “Bohemian Medical Device Summit 2005” will showcase Ars Arthro AG and CoreValve SA in kick-off panel discussion—“Business Models for European Start-Ups”—to be moderated by two of Europe’s most successful VCs: Sofinnova Partners’ Antoine Papiernik and Heid

• 16/08/2005

  Epimmune and IDM S.A. Join Forces to become IDM Pharma, Inc.

• 16/08/2005

  Epimmune et IDM S.A. fusionnent pour devenir IDM PHARMA, INC.

• 25/07/2005

  UPEK® provides Biometric Finger security for the THINKPAD* Tablet

• 21/07/2005

  InfraWorlds acquiert 995 SOFT et entre sur le marché américain

• 25/07/2005

  Infraworlds crée un nouveau format de jeu grand public : SagaZ

• 25/07/2005

  Infraworlds lève 3,55 Millions d'euros

• 03/08/2005

  Infraworlds creates SagaZ, a new game format for the mass market

• 26/07/2005

  Infraworlds receives €3.55 million

• 28/07/2005

  InfraWorlds to acquire 995 SOFT and enter the US market

• 22/08/2005

  Cerenis Therapeutics clôt un premier tour de financement de 25 millions d’euros pour développer des médicaments améliorant les HDL pour le traitement des maladies cardiovasculaires

• 22/08/2005

  Cerenis Therapeutics completes €25 million ($ 30.5 million) Series A financing to progress HDL-related drugs for cardiovascular deseases

• 30/08/2005

  Cerenis Therapeutics announces license agreement with Nippon Chemiphar to develop new therapies based on PPAR Delta Agonist

• 31/08/2005

  NEC Infrontia fait de Jbed CDC, la plate-forme Java d’Esmertec, son standard JVM

• 31/08/2005

  NEC Infrontia adopts Esmertec’s Java runtime platform, Jbed CDC, as the standard JVM for its terminal devices

• 06/09/2005

  Varioptic expands its focus to deliver liquid lenses in new markets

• 26/09/2005

  Addex Pharmaceuticals Initiates Phase I Trials with ADX10059, a novel compound intended for Anxiety and Migraine

• 30/09/2005

  VoluBill announces “Charge it” – a comprehensive mobile data charging solution

• 03/10/2005

  Corevalve names Jack Lips as "European clinical manager"

• 30/09/2005

  VistaPrint Announces Pricing of Initial Public Offering

• 05/10/2005

  Sofinnova Partners annonces the successful stock market flotations of two portfolio companies

• 17/10/2005

  Corevalve's revalving™ system demonstrated ' live' session of TCT 2005 to an audience of 12, 000 international cardiologists and device industry executives

• 25/10/2005

  SpineVision® reports U.S. market penetration milestone

• 20/10/2005

  Corevalve's revalving™ system demonstrated 'live' at opening session of TCT 2005 to an audience of 12,000 interventional cardiologists and device industry executives

• 07/11/2005

  Fovea Pharmaceuticals completes a €20.5 million ( million) Series A financing to develop new drugs for retinal diseases.

• 14/11/2005

  Boehringer Ingelheim and Biolipox sign agreement on a new class of drugs to treat pain and inflammation

• 10/11/2005

  Esmertec China developed and delivered exclusive testing platform to China Mobile Communications Corporation

• 23/09/2005

  Servista wins "BPO Service Provider of the Year" at NOA awards ceremony 2005

• 15/11/2005

  Grenoble, France, 15 November 2005: VoluBill, a leading provider of Data and Content charging solutions for mobile Operators (GPRS, EDGE, 3G, WiFi), has appointed John Aalbers as CEO, effective from the beginning of January 2006.

• 22/11/2005

  Tsinghua Tongfang and 6Wind partnership to take China's booming ICT market by storm

• 22/11/2005

  Tsingha Tongfang et 6Wind à la conquête du marché chinois des TIC

• 17/11/2005

  6Wind contributes to success of KDDI's mobile broadband project

• 17/11/2005

  6Wind contribue au succès du projet de réseau mobile haut débit mené par l'opérateur japonnais KDDI

• 21/11/2005

  Howard Ford ancien Directeur Général d'Equant nommé Président du Conseil d'Administration de Varioptic S.A Lyon, France

• 21/11/2005

  Howard Ford former Managing Director of Equant joins Varioptic as Chairman of the Board Lyon, France

• 19/10/2005

  VARIOPTIC’s pilot line automates production Reproducible manufacturing process yields reliable quality lenses

• 24/11/2005

  Sofinnova Partners a winner in prestigious awards event

• 06/12/2005

  SpineVision® raises $16+ million and spins out its New Technologies Uni to form FlexSpine in Singapore, which will focus on developing motion preservation solutions for spinal surgery

• 13/12/2005

  CoTherix and Respironics Announce Launch of New Portable Inhalation Device to Ventavis Patients

• 13/12/2005

  Corevalve sucessfully inititates first North American clinical trial, using its novel revalving™ system at Montreal Heart Institute to non-surgically replace diseaded aortic heart valve of 64-year-old female patient not eligiblefor open-heart surgery

• 13/12/2005

  Rafaele Tordjman named Partner at Sofinnova Partners

• 14/12/2005

  Professor Peter Van Brummelen and DR. Annick Schwebig join the board of directors of Diatos S.A.

• 29/11/2005

  European Research and Venture Capital Day

• 26/12/2005

  Best Wishes for 2006

• 23/12/2005

  SpineVision® reports a market penetration milestone: 1000th spine surgery performed using Company’s PediGuard™ device, world